Evidence map›Paper›PMID 36998198›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII.

Louise H Hooimeijer, Marjet A Stein-Wit, Marja Aj Voskuilen, Michaël V Lukens, Karina Meijer, Anja Bu Mäkelburg, Rienk Yj Tamminga

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Simoctocog alfa (NuwiqTherapeutic advances in hematology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Louise H HooimeijerPediatric Hematology, Beatrix Children's Hospital, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Marjet A Stein-WitPediatric Hematology, Beatrix Children's Hospital, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Marja Aj VoskuilenDivision of Thrombosis and Hemostasis, Department of Hematology, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Michaël V LukensLaboratory Special Hematology, Department of Laboratory Medicine, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Karina MeijerDivision of Thrombosis and Hemostasis, Department of Hematology, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-9447-0465
Anja Bu MäkelburgDivision of Thrombosis and Hemostasis, Department of Hematology, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Rienk Yj TammingaPediatric Hematology, Beatrix Children's Hospital, Hemophilia Treatment Centre Groningen, 10173University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-7986-7712
University Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2018, Refacto AF

Indexed as

Hemophilia AAdultChildFactor VIIIGenotypeHumansRetrospective StudiesRisk FactorsFactor VIIIantibodiesfactor VIII concentratehemophilia Aimmunitytherapeutics

Identifiers

PMID36998198
PMCPMC10068986
OpenAlexW4362014741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.